Carlo A. Vignoli

Rozzano, 20089, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

Journal: Dermatology and therapy

Published: May 05, 2026

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

Journal: Dermatology and therapy

Published: April 24, 2026

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2026

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Journal: American journal of clinical dermatology

Published: November 05, 2025

First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

Journal: Physical review letters

Published: May 21, 2025

JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients.

JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: May 01, 2025

New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review.

New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review.

Journal: Medicina (Kaunas, Lithuania)

Published: March 07, 2025

Potential role of leptin in Janus kinase 2 inhibitor-associated weight gain: a monocentric retrospective study.

Potential role of leptin in Janus kinase 2 inhibitor-associated weight gain: a monocentric retrospective study.

Journal: Clinical and experimental dermatology

Published: February 07, 2025

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.

Journal: The Journal of dermatological treatment

Published: January 06, 2025

Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study.

Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study.

Journal: Clinical and experimental dermatology

Published: December 03, 2024

Search for a Hidden Sector Scalar from Kaon Decay in the Dimuon Final State at ICARUS.

Search for a Hidden Sector Scalar from Kaon Decay in the Dimuon Final State at ICARUS.

Journal: Physical review letters

Published: November 18, 2024

Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study.

Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study.

Journal: Journal of drugs in dermatology : JDD

Published: August 02, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026